| Longitudinal molecular trajectories of diffuse glioma in adults FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ... Nature 576 (7785), 112-120, 2019 | 390 | 2019 |
| Glioma progression is shaped by genetic evolution and microenvironment interactions FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, ... Cell 185 (12), 2184-2199. e16, 2022 | 201 | 2022 |
| Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancer E Kocakavuk, KJ Anderson, FS Varn, KC Johnson, SB Amin, EP Sulman, ... Nature genetics 53 (7), 1088-1096, 2021 | 95 | 2021 |
| Artificial intelligence and machine learning in nuclear medicine: future perspectives R Seifert, M Weber, E Kocakavuk, C Rischpler, D Kersting Seminars in nuclear medicine 51 (2), 170-177, 2021 | 74 | 2021 |
| Comparative molecular life history of spontaneous canine and human gliomas SB Amin, KJ Anderson, CE Boudreau, E Martinez-Ledesma, E Kocakavuk, ... Cancer Cell 37 (2), 243-257. e7, 2020 | 70 | 2020 |
| Higher levels of kallikrein‐8 in female brain may increase the risk for Alzheimer's disease K Keyvani, Y Münster, NK Kurapati, S Rubach, A Schönborn, ... Brain Pathology 28 (6), 947-964, 2018 | 28 | 2018 |
| Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas E Kocakavuk, KC Johnson, TS Sabedot, HC Reinhardt, H Noushmehr, ... Neuro-oncology 25 (9), 1721-1723, 2023 | 12 | 2023 |
| Young oncologists’ perspective on the role and future of the clinician-scientist in oncology KHJ Lim, CB Westphalen, AS Berghoff, C Cardone, EA Connolly, ... ESMO open 8 (5), 2023 | 5 | 2023 |
| The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen TM Malta, TS Sabedot, NS Morosini, I Datta, L Garofano, W Vallentgoed, ... Cancer research 84 (5), 741-756, 2024 | 2* | 2024 |
| Characteristics of ectopic recurrence of craniopharyngioma: case report and literature review AD Moskalik, E Kocakavuk, KR Bulsara Interdisciplinary Neurosurgery 22, 100804, 2020 | 2 | 2020 |
| Xenografting for disease modeling of intramedullary spinal cord tumors: a systematic review L Rauschenbach, E Kocakavuk, D Pierscianek, Y Ahmadipour, S Kebir, ... Spinal Cord 57 (6), 439-448, 2019 | 1 | 2019 |
| Extent of resection for low-grade gliomas-Prognostic or therapeutic? CJ Kinslow, ALA Garton, AI Rae, E Kocakavuk, GM McKhann, SK Cheng, ... Clinical neurology and neurosurgery 236, 108117, 2024 | | 2024 |
| EPCO-22. LONGITUDINAL MOLECULAR CHARACTERIZATION IDENTIFIES TREATMENT DRIVEN EVOLUTION OF OLIGODENDROGLIOMA T Chowdhury, K Johnson, E Kocakavuk, C Heo, GY Ye, P Ghospurkar, ... Neuro-Oncology 25 (Supplement_5), v128-v128, 2023 | | 2023 |
| ESMO Young Oncologists: ein internationales Netzwerk zur Nachwuchsförderung E Kocakavuk, AM Starzer Forum 38 (5), 354-357, 2023 | | 2023 |
| HEMIZYGOUS CDKN2A DELETION CONFERS WORSE SURVIVAL OUTCOMES IN IDH-MUTANT GLIOMAS E Kocakavuk, KC Johnson, TS Sabedot, HC Reinhardt, H Noushmehr, ... | | 2023 |
| Integrative analysis of longitudinal genomic and non-genetic mechanisms of radiotherapy resistance E Kocakavuk, FS Varn, KC Johnson, RG Verhaak Annals of Oncology 33, S674-S675, 2022 | | 2022 |
| Mutational Signatures of Genotoxic Cancer Therapies E Kocakavuk PQDT-Global, 2022 | | 2022 |
| Geschlechtsspezifische Unterschiede in der Progression der beta-Amyloid-und Kallikrein-8-Pathologie in einem Mausmodell der Alzheimer-Krankheit: eine Untersuchung im … E Kocakavuk Dissertation, Duisburg, Essen, Universität Duisburg-Essen, 2022, 0 | | |
Roel VerhaakYale UniversityVerified email at yale.edu
